Article
Non-coding NFKBIZ 3' UTR mutations promote cell growth and resistance to targeted…
medRxiv · 2021 · Arthur, S. E.; Gao, J.; Healy, S.; Rushton, C. K.; Thomas, N.; Hilton, L. K.; Dreval, K.; Tang, J.; Alcaide, M.; Cojocaru, R.; Mottok, A.; Telenius, A.; Unrau, P.; Wilson, W. H.; Staudt, L. M.; Scott, D. W.; Hodson, D. J.; Steidl, C.; Morin, R. D.
Key facts
| Title | Non-coding NFKBIZ 3' UTR mutations promote cell growth and resistance to targeted therapies in diffuse large B-cell lymphoma |
|---|---|
| First author | Arthur, S. E.; Gao, J.; Healy, S.; Rushton, C. K.; Thomas, N.; Hilton, L. K.; Dreval, K.; Tang, J.; Alcaide, M.; Cojocaru, R.; Mottok, A.; Telenius, A.; Unrau, P.; Wilson, W. H.; Staudt, L. M.; Scott, D. W.; Hodson, D. J.; Steidl, C.; Morin, R. D. |
| Journal | medRxiv |
| Published | May 23, 2021 |
| DOI | 10.1101/2021.05.22.445261 |
| Devices mentioned | K801913, K832204, K871945, K961896 |
| Product codes mentioned | JCJ, PFF, PFT, JQW, JTC |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1